Thelma S. Angeles,Mark A. Ator,Mangeng M. Cheng,Bruce Dorsey,Robert L. Hudkins,Bruce A. Ruggeri
申请号：
US14907514
公开号：
US10028956B2
申请日:
2014.07.31
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This application describes the use of the compound (I) or a salt thereof, either alone or in combination with other therapeutically active agents, for the treatment of particular cancers, including any solid or hematological cancer in which AXL or c-Met is over-expressed.
